Evolent Health, IncEvolent Health, IncEvolent Health, Inc

Evolent Health, Inc

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪1.32 B‬USD
−0.91USD
‪−113.04 M‬USD
‪1.96 B‬USD
‪111.83 M‬
Beta (1Y)
−0.59
Employees (FY)
‪4.7 K‬
Change (1Y)
−400 −7.84%
Revenue / Employee (1Y)
‪417.85 K‬USD
Net income / Employee (1Y)
‪−24.05 K‬USD

About Evolent Health, Inc


CEO
Seth B. Blackley
Headquarters
Wilmington
Founded
2011
FIGI
BBG005CHLM96
Evolent Health, Inc. engages in the provision of healthcare delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. The firm operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of EVH is 11.40 USD — it has decreased by −5.36% in the past 24 hours. Watch Evolent Health, Inc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Evolent Health, Inc stocks are traded under the ticker EVH.
EVH stock has fallen by −22.16% compared to the previous week, the month change is a −52.48% fall, over the last year Evolent Health, Inc has showed a −60.84% decrease.
We've gathered analysts' opinions on Evolent Health, Inc future price: according to them, EVH price has a max estimate of 45.00 USD and a min estimate of 16.00 USD. Watch EVH chart and read a more detailed Evolent Health, Inc stock forecast: see what analysts think of Evolent Health, Inc and suggest that you do with its stocks.
EVH reached its all-time high on Sep 15, 2022 with the price of 39.78 USD, and its all-time low was 3.50 USD and was reached on Mar 17, 2020. View more price dynamics on EVH chart.
See other stocks reaching their highest and lowest prices.
EVH stock is 2.20% volatile and has beta coefficient of −0.59. Track Evolent Health, Inc stock price on the chart and check out the list of the most volatile stocks — is Evolent Health, Inc there?
Today Evolent Health, Inc has the market capitalization of ‪1.32 B‬, it has decreased by −10.73% over the last week.
Yes, you can track Evolent Health, Inc financials in yearly and quarterly reports right on TradingView.
Evolent Health, Inc is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
EVH earnings for the last quarter are 0.04 USD per share, whereas the estimation was 0.31 USD resulting in a −87.08% surprise. The estimated earnings for the next quarter are 0.07 USD per share. See more details about Evolent Health, Inc earnings.
Evolent Health, Inc revenue for the last quarter amounts to ‪621.40 M‬ USD, despite the estimated figure of ‪627.17 M‬ USD. In the next quarter, revenue is expected to reach ‪652.20 M‬ USD.
EVH net income for the last quarter is ‪−23.14 M‬ USD, while the quarter before that showed ‪1.60 M‬ USD of net income which accounts for ‪−1.55 K‬% change. Track more Evolent Health, Inc financial stats to get the full picture.
No, EVH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has ‪4.70 K‬ employees. See our rating of the largest employees — is Evolent Health, Inc on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Evolent Health, Inc EBITDA is ‪130.65 M‬ USD, and current EBITDA margin is 7.85%. See more stats in Evolent Health, Inc financial statements.
Like other stocks, EVH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Evolent Health, Inc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Evolent Health, Inc technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Evolent Health, Inc stock shows the strong sell signal. See more of Evolent Health, Inc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.